Human haemopoietic maturation factor

3. The method of claim 2, wherein the polypeptide is administered to a patient suffering from leukemia.
4. The method of claim 2, wherein the polypeptide is administered to a patient suffering from a blood-related disorder.
5. The method of claim 1, wherein the polypeptide is (b).
6. The method of claim 5, wherein the polypeptide is administered to a patient suffering from leukemia.
7. The method of claim 5, wherein the polypeptide is administered to twat a patient suffering from a blood-related disorder.

United States Patent: 6790826